InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Brownstein Carrie. Director active across 1 company, notably Zentalis Pharmaceuticals, Inc.. In total, 3 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €165k. History available since 3 October 2022. The latest transaction was filed on 4 October 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations